Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene

被引:21
作者
Lima, Francisco Pignataro [1 ,2 ,4 ,5 ]
Bousquet, Marina [1 ,2 ]
Gomez-Brouchet, Anne [3 ]
de Paiva, Geisilene Russano [3 ]
Amstalden, Eliane Maria Ingrid [5 ]
Soares, Fernando Augusto [6 ]
Dastugue, Nicole [1 ,2 ]
Vassallo, Jose [5 ]
Brousset, Pierre [1 ,2 ]
机构
[1] Ctr Physiopathol Toulouse Purpan, INSERM, Toulouse, France
[2] Univ Toulouse 3, Dept Pathol, F-31062 Toulouse, France
[3] Hop Rangueil, Dept Pathol, Toulouse, France
[4] Purpan Hosp, Cytogenet Lab, Toulouse, France
[5] Univ Estadual Campinas, Fac Med Sci, Dept Pathol, Campinas, Brazil
[6] Hosp Canc, Dept Pathol, Sao Paulo, Brazil
关键词
BCL2; c-MYC; fluorescence in situ hybridization; FISH; bone; B-cell lymphoma;
D O I
10.1309/CMPGPYTMFRM6RVQR
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We selected a series of 63 primary diffuse large B-cell lymphomas (DLBCLs) of bone collected in tissue microarrays from centers in France and Brazil. These cases were classified according to the expression of antigens associated with germinal center (GC; n = 42) or non-GC (n = 21) stages of B-cell differentiation. By fluorescence in situ hybridization, we found a substantial number of cases with a rearrangement of BCL2 (9132) and c-MYC (n = 3), whereas the PAX5, BCL6, BCL1/cyclin D1, and ALK genes were in germline configuration. It is interesting that I case, with a GC phenotype, showed dual B CL2 and c-MYC rearrangement. The majority of the cases with rearrangements were of the GC phenotype. These results, associated with the lack of BCL6 rearrangement, suggest that bone DLBCL represents a specific group within extranodal B-cell lymphomas.
引用
收藏
页码:723 / 726
页数:4
相关论文
共 50 条
  • [41] Spinal lesion as the first manifestation of high-grade B-cell lymphoma, with MYC and BCL2 rearrangements
    Ye, Yunxia
    Zhang, Wenyan
    Zhao, Sha
    Jiang, Lili
    Liu, Weiping
    Long, Yanhong
    Wan, Ying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (08): : 8858 - 8862
  • [42] Double-Expressor Phenotype (BCL-2/c-MYC Co-expression) of Diffuse Large B-Cell Lymphoma and Its Clinicopathological Correlation
    Hashmi, Atif A.
    Iftikhar, Syeda N.
    Nargus, Gul
    Ahmed, Omer
    Asghar, Ishaq Azeem
    Shirazi, Umme Aiman
    Afzal, Anoshia
    Irfan, Muhammad
    Ali, Javaria
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [43] Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence
    Bogusz, Agata M.
    Kovach, Alexandra E.
    Le, Long P.
    Feng, Derek
    Baxter, Richard H. G.
    Sohani, Aliyah R.
    PLOS ONE, 2017, 12 (02):
  • [44] Expression of c-Myc, Bcl2, Bcl6, and Cyclin D1 in High-Grade B-Cell Lymphoma
    Ali, Seemal
    Rathore, Zonaira
    Jahangir, Fizza
    Rafique, Zubaria
    Chughtai, Akhtar S.
    Atiq, Aribah
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [45] The Spectrum of MYC Alterations in Diffuse Large B-Cell Lymphoma
    Xia, Yang
    Zhang, Xinlian
    ACTA HAEMATOLOGICA, 2020, 143 (06) : 520 - 528
  • [46] Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell Lymphoma
    Roh, Jin
    Yoon, Dok Hyun
    Lee, Yoon Kyoung
    Pak, Hyo-Kyung
    Kim, Sang-Yeob
    Han, Jae Ho
    Park, Joon Seong
    Jeong, Seong Hyun
    Choi, Yoon Seok
    Cho, Hyungwoo
    Suh, Cheolwon
    Huh, Jooryung
    Lee, Dae Ho
    Park, Chan-Sik
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022, 46 (03) : 289 - 299
  • [47] Cytomorphologic Findings of B-Cell Lymphomas With Concurrent IGH/BCL2 and MYC Rearrangements (Dual-Translocation Lymphomas)
    Santos, Gilda da Cunha
    Ko, Hyang Mi
    Saieg, Mauro Ajaj
    Boerner, Scott L.
    Lai, Shui Wun
    Bailey, Denis
    Geddie, William R.
    CANCER CYTOPATHOLOGY, 2011, 119 (04) : 254 - 262
  • [48] c-myc gene mutation in gastric mucose-associated lymphoid tissue (MALT) lymphoma and diffuse large B-cell lymphoma
    Hiyama, T
    Haruma, K
    Kitadai, Y
    Ito, M
    Masuda, H
    Miyamoto, M
    Tanaka, S
    Yoshihara, M
    Sumii, K
    Shimamoto, F
    Chayama, K
    ONCOLOGY REPORTS, 2001, 8 (02) : 289 - 292
  • [49] Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
    Johnson, Nathalie A.
    Slack, Graham W.
    Savage, Kerry J.
    Connors, Joseph M.
    Ben-Neriah, Susana
    Rogic, Sanja
    Scott, David W.
    Tan, King L.
    Steidl, Christian
    Sehn, Laurie H.
    Chan, Wing C.
    Iqbal, Javeed
    Meyer, Paul N.
    Lenz, Georg
    Wright, George
    Rimsza, Lisa M.
    Valentino, Carlo
    Brunhoeber, Patrick
    Grogan, Thomas M.
    Braziel, Rita M.
    Cook, James R.
    Tubbs, Raymond R.
    Weisenburger, Dennis D.
    Campo, Elias
    Rosenwald, Andreas
    Ott, German
    Delabie, Jan
    Holcroft, Christina
    Jaffe, Elaine S.
    Staudt, Louis M.
    Gascoyne, Randy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) : 3452 - 3459
  • [50] The impact of BCL-2/MYC protein expression and gene abnormality on primary central nervous system diffuse large B-cell lymphoma
    Yin, Wenjuan
    Xia, Xianghou
    Wu, Meijuan
    Yang, Haiyang
    Zhu, Xiu
    Sun, Wenyong
    Ge, Minghua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (06): : 2215 - 2223